Sitemap
Antibiotics, Vaccines & Prophylaxis
- MIC-to-MBC Ratio
- Fractional Inhibitory Concentration (FIC)
- Fractional Bactericidal Concentration (FBC)
- Antibiotic Serum Level-to-MIC Ratio
- Inhibitory Quotient of Ellner and Neu
- Categorical Comparison of Antibiotic Susceptibility Test Results with the Reference Results
- Essential Agreement Between Antibiotic Susceptibility Test Results with Reference Results
- D Zone Test for Inducible Clindamycin Resistance in Methicillin Resistant Staphylococcus Aureus (MRSA)
- Patterns of Antibiotic Interaction (Additive, Synergistic, Antagonistic) During Disk Diffusion Testing
- Inoculum Effect
- Minimum Lethal Concentration (MLC) of Metronidazole for Trichomonas vaginalis
- Paradoxical Bactericidal Activity of Beta-Lactam Antibiotics (Eagle Effect)
- Maintenance Dosage Fraction of an Antibiotic Based on Estimated Drug Clearance
- Maintenance Dosage Fraction of an Antibiotic Based on the Fractional Rate Constant
- Dosing Aminoglycosides in Renal Failure Using the Method of Sarubbi and Hull
- Equation of Matzke et al for Dosing Vancomycin in Renal Failure
- Dosing Amantadine in Renal Failure
- Foscarnet Dose for CMV Retinitis in Renal Dysfunction
- Dosing Nomogram of Moellering et al for Vancomycin in a Patient with Impaired Renal Function
- Equation of Pea et al for Estimating the Infusion Rate for Vancomycin in Critically-Ill Patients
- Loading Dose of an Aminoglycoside for an Obese Patient
- Loading Dose of an Aminoglycosides for a Patient Who is Underweight
- Contraindications to Extended Interval Aminoglycoside Dosing (EIAD)
- Extended Interval Aminoglycoside Administration Using the Lower Dosage
- Extended Interval Aminoglycoside Administration Using the Higher Dosage
- Weight-Based Extended-Interval Gentamicin Dosing Protocol of Hoff et al for a Critically-Ill Neonate
- Weight-Based Extended-Interval Gentamicin Dosing Nomogram of Murphy and Roether for a Neonate: Lower Trough Serum Concentration
- Weight-Based Extended-Interval Gentamicin Dosing Nomogram of Murphy and Roether for a Neonate: Higher Trough Serum Concentration
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Determining the Loading Dose
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Calculating the elimination rate constant (k)
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Estimating the Volume of Distribution
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Determining the Dosage Interval
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Determining the Maintenance Dose
- Method of Sawchuk and Zaske for Dosing an Aminoglycoside: Calculating the New C(min-ss)
- 1996 CDC Guidelines for Prophylaxis to Prevent Group B Streptococcal Infection in Newborns
- CDC Algorithm for Secondary Prevention of Early-Onset Neonatal Sepsis Due to Group B Streptococcus
- CDC Algorithm for Antibiotic Selection for Intrapartum Antibiotic Prophylaxis Against Group B Streptococcus
- CDC Algorithm for Intrapartum Antibiotic Prophylaxis Against Group B Streptococcus in a Woman with Preterm Premature Rupture of the Membranes
- Indications for Intrapartum Antibiotic Therapy for a Pregnant Woman to Prevent Neonatal Group B Streptococcus Infections
- Criteria for Adequate Intrapartum Antibiotic Prophylaxis (IAP)
- Preventive Therapy for Persons with Positive Tuberculin Skin Test (PPD) Reactions
- Indications for Prophylaxis to Mycobacterium tuberculosis in Solid Organ Transplant Recipients
- Indications for Prophylaxis to Mycobacterium tuberculosis in Patients Taking Infliximab
- Indications for Considering the Administration of BCG (Bacille Calmette-Guerin) Vaccine
- Treatment Algorithm of the ATS, CDC and IDSA for a Patient with a High Clinical Suspicion for Active Tuberculosis
- Treatment Algorithm of the ATS, CDC, and IDSA for a Patient with Possible Tuberculosis and Negative Initial Sputum Smears
- Length of Antituberculous Therapy for a Patient with Extrapulmonary Tuberculosis
- Management of an Interruption in Antituberculous Therapy
- Reasons of Wilson et al for Failure of an HIV-Infected Adult with Tuberculosis to Clinically Respond to Antituberculous Chemotherapy
- Rabies Post-Exposure Prophylaxis
- Algorithm for Rabies Exposure Management
- Complications of Suwansrinon et al Associated with Injecting Rabies Immunoglobulin Into a Bite Wound
- Exposure to Bats and Rabies Prophylaxis
- Recommendations for Pneumococcal Vaccination
- Recommendations for Revaccination with the Pneumococcal Vaccine
- Prophylaxis for Bacterial Endocarditis with Dental Procedures in 1997
- Revised Recommendations for Prophylaxis to Prevent Bacterial Endocarditis After Dental Procedures
- Prophylaxis for Bacterial Endocarditis with Surgical Non-Dental Procedures
- Algorithm for Prophylaxis in Suspected Mitral Valve Prolapse
- Prophylaxis for Dental Procedures in Patients with Total Joint Replacements
- Prophylactic Antibiotics before Biliary Tract Surgery
- Prophylactic Antibiotic Therapy After Dog Bites
- Prophylactic Antibiotic Regimen of Such and Runyon for a Patient with Cirrhosis and Ascites
- Recommendations of Simpson et al for Antibiotic Prophylaxis and Therapy in a Patient with a Gunshot Wound
- Prophylaxis of Person with a Laboratory Exposure to a Brucella Species
- American Heart Association 2007 Recommendations for Prophylaxis Prior to a Dental Procedure for Prevention of Bacterial Endocarditis
- Antibiotic Prophylaxis Prior to Vaginal Delivery for Prevention of Bacterial Endocarditis
- Antibiotic Prophylaxis Prior to a Nondental Procedure for Prevention of Bacterial Endocarditis
- Risk Factors of Rangaraj et al for Breakthrough Bacteremia in a Patient with Cancer
- Risk Factors for Breakthrough Infection in a Child with Primary Vesicoureteral Reflux During Prophylactic Antibiotic Therapy
- Antibiotic Prophylaxis Protocol of Lindstedt et al for Core Biopsy of the Prostate
- Criteria of Davies and Wilson for Prophylactic Antibiotic Therapy of a Patient with Bronchiectasis
- Monitoring the Response to Prophylactic Antibiotic Therapy for a Patient with Bronchiectasis
- Chemoprophylaxis to Influenza A With Amantadine or Ramantadine
- Recommendations for Influenza Vaccination
- Contraindications to the Use of the Intranasal Live Influenza Vaccine (Flumist)
- Criteria of Freedman and Leder for a Patient Who Is Inadequately Vaccinated Against Influenza
- Use of Oseltamivir to Treat or Prevent Influenza
- Indications for Chemotherapy of a Patient with Influenza
- Chemoprophylaxis for Meningococcal Exposure
- Recommendations for Meningococcal Vaccination
- Recommendations of Steffen for the Quadrivalent (4V) Meningococcal Vaccine
- 1998 CDC Recommendations for Postexposure Prophylaxis in Health Care Workers
- Indications of Welch and Mason for HIV Prophylaxis in a Patient Who Has Been Raped
- Selection of Patients for Outpatient Parenteral Antibiotic Therapy
- Indications for Use of an Infusion Pump by a Patient Receiving Home Parenteral Antibiotic Therapy
- Criteria for Outpatient Antibiotic Therapy for a Patient with Bacterial Meningitis
- Contraindications to the Use of Mefloquine for Malaria Prophylaxis
- Use of Doxycycline for Malaria Prophylaxis
- Algorithm of Connor for Antimalarial Prophylaxis Based on Sensitivity in Area
- Reasons Travelers Give for Not Taking Malaria Prophylaxis
- Dosing Malarone (Atovaquone and Proguanil HCl) for Prophylaxis or Therapy of Plasmodium falciparum
- WHO Patterns of Drug Resistance in Malaria
- Identification of Plasmodium falciparum Malaria Resistant to Sulfadoxine and Pyrimethamine Therapy Using Molecular Markers of DHFR and DHPS
- Genotype Resistance Index (GRI) and Genotype Failure Index (GFI) for Epidemiologic Studies of Drug Resistant Plasmodium falciparum
- Classifying the Risk of Malaria Transmission for a Traveler
- Stand-By Emergency Treatment (SBET) for Malaria
- Contraindications for Primaquine Therapy to Eliminate the Persistent Liver Stages of Plasmodium vivax or ovale
- WHO 2005 Classification of Malaria Treatment Response
- Impact of Antimalarial Therapy on Calcineurin Inhibitor Levels in a Solid Organ Transplant Recipient
- Extensive Drug Resistance (XDR) in Malaria
- Factors of Goodyer et al for the Choice of a Prophylactic Antimalarial
- Chemoprevention and Management of Traveler's Diarrhea
- Potential Drug Interactions in a Traveler Receiving Trimethoprim-Sulfamethoxazole and an Antimalarial Drug
- Postexposure Prophylaxis for Anthrax
- Predictive Index for Antibiotic Resistance in Gram-Negative Bacteremia
- Situations Where Vancomycin Use Should Be Avoided to Minimize Emergence of Drug Resistant Strains
- Centers for Disease Control (CDC) 12 Step Program to Prevent Antimicrobial Resistance Among Hospitalized Patients
- Prediction Rule of Tacconelli et al for Identifying Patients at Risk for Vancomycin Resistant Enterococci on Admission to a Hospital
- Risk Factors of Lynch and Martinez for Macrolide Resistance in Streptococcus pneumoniae
- Risk Factors of Lautenbach et al for Fluoroquinolone Resistance in Nosocomial Infections with Escherichia coli and Klebsiella pneumoniae
- Classification Tree of El Solh et al for Predicting Antibiotic Resistance in a Pneumonia Affecting an Elderly Institutionalized Patient
- Risk Factors of Niederman et al for Multidrug Resistant Bacterial Pneumonia Acquired in a Health Care Setting
- Risk Factors of Pfaller and Segreti for Detecting a Patient with Bacteria Producing an Extended-Spectrum Beta-Lactamase
- Risk Factors for Hospital and Community Acquired Methicillin or Oxacillin Resistant Staphylococcus Aureus (MRSA, ORSA)
- Risk Factors of Ohmagari for Infection with a Multidrug-Resistant Pseudomonas aeruginosa in a Patient with Cancer
- Risk Factors of Rentz et al for Infection with Ampicillin Resistant Bacteria in a Newborn Infant Receiving Group B Streptococcal Prophylaxis
- Vancomycin Tolerance in a Cancer Patient with a Gram Positive Bacterial Infection
- Criteria of Paterson for Multidrug Resistant and Panresistant Pseudomonas aeruginosa
- When To Suspect That a Patient May Have Drug-Resistant Mycobacterium tuberculosis
- WHO and CDC Definition for Extensively Drug-Resistant Mycobacterium tuberculosis
- Risk Factors of Ansari et al for Infection with Multidrug-Resistant Stenotrophomonas maltophilia in a Patient with Cancer
- Antibiotic Selection for an Extended Spectrum Beta-Lactamase (ESBL) Producing Bacteria
- Risk Factors of Kang et al for Mortality Associated with Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli
- Risk Factors of Tumbarello et al for Suspecting Methicillin-Resistant Staphylococcus aureus Bacteremia in an HIV-Infected Patient
- Risk Factors of Wright et al for a Urinary Tract Infection Caused by a Multidrug Resistant Uropathogen
- Risk Factors of Harris et al for Patient Colonization with an Extended Spectrum Beta-Lactamase Producing Bacteria on ICU Admission
- Criteria of Paterson and Doi for a Gram-Negative Bacillus Showing Extreme Drug Resistance (XDR)
- Risk Factors of DuPont for Infection with a Fluoroquinolone-Resistant Campylobacter Species
- Features of Extensively Drug-Resistant Tuberculosis in South Korea
- Risk Factors of Sotto et al for Antibiotic Resistant Escherichia coli in a Hospitalized Patient with a Urinary Tract Infection
- Model of Shorr et al for Identifying a Patient with Health Care-Associated Pneumonia Caused by Antibiotic-Resistant Bacteria
- Risk Factors of Nseir and Ader for Multidrug-Resistant Bacteria Causing an Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)
- Predicting Antibiotic Resistance in a Child with a Recurrent Urinary Tract Infection Based on the Study of Conway et al
- Risk Factors of Swenson et al for an Intra-Abdominal Infection Being Caused by Antibiotic Resistant Pathogens
- Multi-Drug Resistant Neisseria Gonorrhoeae
- Predictive Score of Boonsarngsuk et al for Identifying a Patient in Thailand with Drug-Resistant Tuberculosis
- Predictors of Schechner et al for Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae by a Patient Known To Be a Carrier in the Past
- Penicillin Tolerance in Group B Streptococci (Streptococcus agalactiae)
- Risk Factors of Fernandez et al for a Patient with Cirrhosis Having Multi-Drug Resistant Bacteria
- Score of Tumbarello et al for Identifying a Patient Colonized with Extended Spectrum Beta-Lactamase Producing Enterobacteriaceae
- Risk Factors of Jenkins et al for Drug Resistant Streptococcus pneumoniae (DRSP)
- Risk Factors of Razizi et al for a Patient in the Intensive Care Unit (ICU) Being Colonized with Extended-Spectrum beta-Lactamase (ESBL) Producing Enterobacteria
- Prediction Rule of Yoon et al for Identifying a Patient Admitted to the Intensive Care Unit (ICU) Who May Be Colonized with Vancomycin-Resistant Enterococci (VRE)
- Algorithm for Administering the Measles-Mump-Rubella (MMR) Vaccine in Children with Egg Allergy
- Identification of Patients With a Higher Risk of Adverse Reaction to Japanese Encephalitis (JE) Vaccine
- Categories of Adverse Events Associated with Vaccines
- Vaccines Not Recommended for Immunocompromised Patients
- Factors Suggesting a Causal Association Between a Vaccination and an Adverse Event
- Method of James et al for Administering Influenza Vaccine to a Patient with Egg Allergy
- Features of the Oculorespiratory Syndrome (ORS) Associated with Influenza Vaccination
- Criteria of Scheifele et al for Evaluating an Injection Site Reaction Following Vaccination
- Classification of Woo et al for Extensive Limb Swelling After Immunization
- Evaluating a Patient for Local and Systemic Reactions to a Vaccine
- Local Reactions to Live Measles Virus Vaccine in Previous Recipients of a Killed Measles Virus Vaccine
- Risk of Disease Transmission Associated with a Needle-Free Jet Injector
- Yellow Fever Vaccine-Associated Neurotropic Disease (YEL-AND, Postvaccinal Encephalitis)
- Yellow Fever Vaccine-Associated Viscerotropic Disease (YEL-AVD, Postvaccinal Multiple Organ Failure)
- Valid and Invalid Reasons of Lane et al for Not Vaccinating a Child
- Vaccinating a Patient with Hemophilia or Other Serious Bleeding Disorder
- Prevention of Secondary Injuries Associated with Syncope Following Vaccination
- Recognition of a Syncopal or Vasovagal Reaction Associated with an Injection or Venipuncture
- Cutaneous Pseudolymphoma at a Vaccination Site
- Transmission of Yellow Fever By Breastfeeding After Administration of a Live Virus Vaccine to the Mother
- Risk Factors of Klein et al for Apnea After Immunizing a Patient in the Neonatal Intensive Care Unit
- Therapeutic Failure in the Treatment of Head Lice
- Problems with Using Malathion for the Treatment of Lice
- Measures to Prevent Serious Infection in the Asplenic Patient
- Recommendations of Esteve et al for Vaccinating a Patient with Inflammatory Bowel Disease (IBD)
- Recommendations of Kotton et al for Vaccinations in a Solid Organ Transplant Recipient
- CDC Recommendations for Treatment with Interferon in Patients with Hepatitis C
- Contraindications for Therapy with Interferon in Viral Hepatitis C
- Recommendations for Vaccination Against Hepatitis A Virus
- Recommendations for Postexposure Prophylaxis to Hepatitis A Virus
- Recommendations for Vaccination Against Hepatitis B Virus
- Initial Dosing of Copegus (Ribavirin) and Pegasys (Interferon alfa-2b) in the Therapy of Chronic Viral Hepatitis C
- Adjusting the Dose of Copegus (Ribavirin) in a Patient with Chronic Viral Hepatitis C
- Adjusting the Dose of Interferon alfa-2b in a Patient with Chronic Viral Hepatitis C
- Algorithm of Fiore for Determining the Need for Immunoprophylaxis After Exposure to Food Prepared By a Food Handler with Hepatitis A
- Primary Nonresponsiveness to Hepatitis B Virus Vaccine
- Risk Factors of Bani-Sadr et al for Hepatic Decompensation During Interferon-Ribavirin Therapy in a Patient Coinfected with Hepatitis C Virus and HIV
- Treatment Regimen of Keeffe et al for a Patient with Noncirrhotic HBeAg-Positive Hepatitis B Viral (HBV) Infection
- Treatment Regimen of Keeffe et al for a Patient with Noncirrhotic HBeAg-Negative Hepatitis B Viral (HBV) Infection
- Criteria of Mao et al for Treatment Response in Chronic HBeAg-Positive Viral Hepatitis B
- Antitoxin and Immune Globulin Therapy in Botulism
- Prophylactic Measures to Prevent Infection in Patients with Sickle Cell Disease
- Evaluation of a Patient with HIV Virologic Failure for Drug Regimen Adherence
- Indications for Starting Antiretroviral Therapy in a Patient with Chronic HIV Infection
- Indications to Change an Antiretroviral Therapeutic Regimen
- Hazards of Alcohol and Drug Abuse in a Patient Receiving Antiretroviral Therapy for HIV Infection
- Risk Factors of Mugavero et al for a Patient with HIV Manifesting "No Show" Behavior
- WHO Recommendations for Managing Toxicity Associated with Antiretroviral Drug Therapy
- WHO Criteria for Treatment Failure in a Patient on a First-Line Antiretroviral Drug Regimen
- Risk Score of Robbins et al for Predicting Virologic Failure for an HIV Outpatient
- Drug Holiday (Structured Therapy Interruption) in a Patient with HIV Infection
- Method of Wong-Beringer et al for Switching from Intravenous to Oral Antibiotic Dosing
- Contraindications for the Use of Smallpox Live Vaccinia Virus Vaccine
- Evaluation of the Patient Response to Smallpox Vaccination
- Adverse Reactions Following Smallpox Vaccination
- Contraindications for the Use of Smallpox Vaccine in Patients with Heart Disease
- Vaccinia Gangrenosa (Vaccinia Necrosum, Progressive Vaccinia)
- Indications for Passive Immunization with Varicella Zoster Immune Globulin (VZIG)
- Recommendations for Active Varicella Vaccination
- Indications and Contraindictions to Vaccination Against Herpes Zoster (Zostavax, Shingles Vaccine)
- Recommendations for Vaccination to Measles, Mumps and Rubella
- Contraindications and Precautions for Administration of Diphtheria-Tetanus-Pertussis (DTP) Vaccine
- Tetanus Prophylaxis in Wound Management
- Recommendations for Lyme Disease Vaccination
- Management of a Patient with an Attached Tick
- Management of a Patient with Carditis Associated with Lyme Disease
- Recommendations for Vaccination Against Japanese Encephalitis (JE) Virus
- The American Academy of Pediatrics (AAP) 1998 Recommendations for Palivizumab and RSV-IGIV to Prevent RSV Infection
- Method of Robinson et al for Approaching a Patient with a Suspected Reaction to a Penicillin or Cephalosporin Antibiotic
- Indications for Skin Testing with a Penicillin or Cephalosporin Antibiotic
- Skin Test for Penicillin Allergy
- Oral Desensitization Protocol of Gluckstein and Ruskin for a Patient with a Sensitivity Reaction to Trimethoprim-Sulfamethoxazole
- Intravenous Desensitization Protocol of Ghosal and Taylor for Ceftazidime
- Oral Protocol of Sullivan for Desensitization of a Patient with Allergy to a Beta-Lactam Antibiotic
- Intravenous Desensitization Protocol of Gea-Banachloche and Metcalfe for Ciprofloxacin
- Factors Associated with Fear of Injection or Fainting Afterwards
- Criteria for the Diagnosis of Blood-Injection-Injury Specific Phobia
- Reasons Identified by Meszaros et al for Why Some Parents Do Not Have Their Children Vaccinated Against Pertussis
- Enabling and Preventing Factors of Friede et al for Vaccination in Developing Countries, with a Modification of the Adversity Index
- Factors of Salmon et al for Identifying Parents Who May Refuse Vaccination for Their Children
- Observations of Mercado on the Vaccination of a Patient with Systemic Lupus Erythematosus (SLE)
- Indications for Prophylaxis Against Pneumocystis Carinii in a Patient with HIV Disease
- Indications for Prophylaxis Against Mycobacterium avium-intracellulare (MAI) complex Infection in a Patient with HIV Disease
- Indications for Prophylaxis Against Cytomegalovirus (CMV) Retinitis in a Patient with HIV Disease
- Indications for Prophylaxis Against Cryptococcosis in a Patient with HIV Disease
- Indications for Prophylaxis Against Toxoplasmosis in a Patient with HIV Disease
- Indications for Prophylaxis Against Noncryptococcal Fungal Infections in a Patient with HIV Disease
- Determining Vaccine Efficacy
- Reasons Why a Vaccine May Not Be Effective in Preventing an Infection
- Herd Immunity (Herd Protection)
- Dosing Albendazole in Hydatid Disease and Neurocysticerosis
- Dosing Thiabendazole for a Patient with a Nematode Infection
- Dosing Ivermectin for a Patient with a Nematode Infection
- Dosing Niclosamide for a Patient with an Intestinal Cestode (Tapeworm) Infection
- Treatment of Toxocariasis with Visceral Larva Migrans
- Therapeutic Strategies of Junghanss et al for Cystic Echinococcosis
- Indications for Prophylaxis Against Pneumocytis Carinii in an HIV-Negative Patient
- Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) with Trimethoprim Sulfamethoxazole (TMP-SMX)
- Therapy of Pneumocystis Carinii Pneumonia (PCP) with Trimethoprim Sulfamethoxazole (TMP-SMX)
- Vaccination and Travel Advice for a Person Making the Pilgrimage to Mecca (Hajj)
- Dosing Trimethoprim-Sulfamethoxazole for Urinary Tract Infection, Acute Otitis and Other Infections in Children
- Risk Factors for Nephrotoxicity Associated with Amphotericin B Deoxycholate Therapy
- Protocol of Kiwan and Anaissie for Treating Invasive Pulmonary Aspergillosis
- Indications of Anaissie et al for Antifungal Therapy in a Cancer Patient at Risk for Fungal Infection
- Algorithm of Spellberg et al for Empirical Antifungal Therapy in a Patient with Known or Suspected Disseminated Candidiasis
- Algorithm of Spellberg et al for Modifying Antifungal Therapy in a Patient with Disseminated Candidiasis
- Risk Factors of Garey et al for Mortality in a Patient Treated with Fluconazole for Candidemia
- Indications for the Use of Amphotericin B in Treating a Patient with Blastomycosis
- Criteria for Apparent Cure in a Patient Treated for Paracoccidioidomycosis (South American Blastomycosis)
- Risk Factors of Howard et al for Resistance of Aspergillus fumigatus to an Azole
- Dose-Related Toxicity Associated with Itraconazole Therapy
- Recommendations of Stevens et al for Prophylaxis Following a Laboratory Exposure to Coccidioides immitis
- Factors of Ampel et al Influencing the Decision to Treat a Patient with Primary Pulmonary Coccidioidomycosis
- Treatment Recommendations of Bariola et al for a Patient with Blastomycosis in the Central Nervous System
- Differential Diagnosis of Apparent Failure with Antifungal Therapy
- Criteria of Segal et al for Therapeutic Response in a Patient with Invasive Candidiasis
- Rule of Paphitou et al for Risk-Stratified Prophylaxis Against Candida Infections of a Patient in the Surgical Intensive Care Unit (ICU)
- Candidates for Postexposure Prophylaxis to Prevent Pertussis
- The Standard Regimen for Selective Digestive Tract Decontamination
- Determining If Methenamine Is Appropriate for Use as a Urinary Antiseptic Agent
- Absolute and Relative Contraindications to Administration of the Live, Oral Rotavirus Vaccine
- Immunoglobulin Administration Following Exposure to Measles
- Contraindications and Precautions for Immunization with Yellow Fever Vaccine
- Indications for Immunization with Yellow Fever Vaccine
- Criteria for a Valid Yellow Fever Vaccination Certificate
- Classification and Regression Tree (CART) Analysis of Moise et al for Predicting Response of a Nosocomial Staphylococcus aureus Pneumonia to Vancomycin
- Expedited Partner Therapy (EPT) and Patient-Delivered Partner Therapy (PDPT)
- Hazards of Expedited Partner Therapy (EPT)
- Why a Patient with a Sexually-Transmitted Disease May Avoid Medical Treatment
- Macrolide Resistance in Treponema pallidum (Syphilis)
- Recommendations for Needle Length and Injection Site for an Intramuscular Injection
- Abnormal Bacterial Morphology Associated with Antibiotic Therapy
- Management Scheme of Montoya and Remington for a Pregnant Woman with Toxoplasmosis Acquired During Pregnancy
- Recommendations of Kunin for the Management of a Catheter-Associated Urinary Tract Infection (CAUTI)
- 2002 IDSA Guidelines for Initial Management of a Cancer Patient with Neutropenia
- 2002 IDSA Guidelines for a Cancer Patient with Neutropenia Who Is Afebrile After Initial Empiric Antibiotic Therapy
- 2002 IDSA Guidelines for the Neutropenic Cancer Patient Who Is Still Febrile After 3 to 5 Days of Empiric Antibiotic Therapy
- 2002 IDSA Guidance on the Duration of Antibiotic Therapy in a Cancer Patient with Febrile Neutropenia
- Indications of the IDSA for Addition of an Antibiotic Active Against a Gram-Positive Organism to an Empiric Regimen for Neutropenia with Fever
- Indications for Administration of a Typhoid Fever Vaccine
- Administration of the Capsular Vi Polysaccharide Vaccine for Prevention of Typhoid Fever
- Administration of the Oral Ty21a Vaccine for Prevention of Typhoid Fever
- Empirical Outpatient Therapy for a Patient with Community Acquired Pneumonia Based on the IDSA/ATS Guidelines
- Criteria of van der Valk for a Patient with an Exacerbation of Chronic Obstructive Pulmonary Disease Who Does Not Require Antibiotic Therapy
- Delayed Defervescence in a Patient Being Treated for a Lung Abscess
- Myospherulosis
- Possible Infectious Complications of a Rat Bite
- Criteria for Appropriate vs Inappropriate Initial Antimicrobial Therapy of a Serious Bacterial Infection
- Criteria of Cadieux et al for Inappropriate Antibiotic Prescribing in Primary Care
- Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Low Risk Infection
- Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Moderate Risk Pneumonia
- Algorithm of Schuetz et al for Using the Serum Procalcitonin Concentration to Guide Antibiotic Therapy: Severe Infection or Sepsis
- Guidelines of Nobre et al for Using the Serum Procalcitonin Concentration to Treat a Patient with Sepsis
- Selection of Antibiotics to Treat Sepsis Caused By Vibrio Vulnificus
- Indications of a Therapeutic Response in a Patient with Giardiasis
- Reasons for Giardiasis to Be Refractory to Therapy
- Antiviral Drug Resistance in Cytomegalovirus (CMV)
- Monitoring the Response of Osteomyelitis to Antibiotic Therapy
- Recommendations of Tarr et al for Managing a Patient with Hemolytic Uremic Syndrome (HUS) Caused By Shiga Toxin-Producing Escherichia coli
- Criteria of Tarr et al for Resolution of Hemolytic Uremic Syndrome (HUS) Caused By Shiga Toxin-Producing Escherichia coli
- Initial Intensive Therapy for Meliodosis
- Switching to Meropenem During Initial Intensive Therapy of Meliodosis
- Oral Eradication Therapy of Meliodosis with Amoxicillin-Clavulanate
- Oral Eradication Therapy of Meliodosis with Trimethoprim-Sulfamethoxazole
- Criteria of Hoelzer et al for When to Stop Antibiotic Therapy in a Child with Complicated Appendicitis
- CDC Recommendations for When to Consult an Expert for HIV Postexposure Prophylaxis (PEP)
- NICE Recommendations for Management of a Pediatric Patient with Gastroenteritis
- Score of Aliberti et al for Identifying a Patient with Community-Acquired Pneumonia at Risk for a Multi-Drug Resistant Pathogen
- Risk Factors of Shindo et al for Community-Acquired or Healthcare-Associated Pneumonia with a Drug-Resistant Pathogen (DRP)
- Discolored Leg Syndrome (DLS) Following Administration of the DTP-IPV-Hib Vaccine to an Infant
- Vaccination Against Viral Hepatitis A and B in a Patient with Chronic Liver Disease (CLD)
- Impaired Antibody Response to Vaccination During Rituximab or Abatacept Therapy
- Antibody Response (AR) to Vaccination
- Immontherapeutic Vaccine for a Patient with Severe Pythiosis
- Management of a Patient with Pythiosis
- Errors in the Administration of Oral Live Rotavirus Vaccine
- Findings Indicative of Treatment Failure in a Patient Treated for Syphilis
- Safety Assessment of a Probiotic and Qualified Presumption of Safety (QPS)
- CDC Recommendations for Vaccination of a Patient with Cochlear Implants
- Ways to Improve the Vaccination Rates for Hospitalized Patients
- World Health Organization (WHO) Categories of Contact with a Potentially Rabid Animal
- Factors of Wilde That Contribute to a Failure of Post-Exposure Rabies Prophylaxis
- Recommendations for Administering Both 13- and 23-Valent Pneumococcal Vaccines to a Patient >= 65 years of Age
- CART Model of Moore et al for Predicting Failure of Vancomycin Therapy for MRSA Bloodstream Infection
- Guillain-Barre Spectrum Disorders (Guillain-Barre Syndrome, Miller Fisher Syndrome, Bickerstaff Syndrome) Associated with Vaccination
- Deciding Whether to Test for Immunity Before Vaccination or Not
- Primary and Secondary Measles Vaccine Failures: Measurement of IgG Avidiity and IgM Antibodies
- Score of Stajadinovic et al for Predicting Treatment Failure in a Patient with a Suppurative Kidney Infection
- Factors Associated with Substantial Risk for Acquiring HIV Infection
- CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Male Who Has Sex with Males (MSM)
- CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Heterosexual Activity
- CDC Guidelines for Preexposure Prophylaxis to Prevent HIV Infection: Injection Drug User (IDU)
- Risk Factors of Sanchez et al for Spread of Multi-Drug Resistant (MDR) Klebesiella pneuomoniae in Critically-Ill Burn Patients
- Score of Martin et al for Distinguishing Carbapenem-Resistant from Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae
- Risk Factors of Schwaber et al for Hospital Acquisition of Carbapenem-Resistant Klebsiella pneumoniae
- Risk Factors of Fu et al for Extensive Drug Resistance and Mortality in an Older Adult with Acinetobacter baumannii Bacteremia
- Risk Factors for a Burn Patient Becoming Colonized with Vancomycin-Resistant Enterococci (VRE)
- Clinical Rule of Ma et al for Predicting Antibiotic-Resistant Bacterial Pneumonia in an Older Chinese Patient
- Clinical Decision Rule of Faine et al for Identifying an Adult with an Antimicrobial-Resistant Urinary Pathogen in the Emergency Department
- Recommendations of Bradley et al for Minimizing Antibiotic Resistance
- Model of King et al for Predicting Oral Antibiotic Treatment Failure of a Child with Rapid Breathing Community-Acquired Pneumonia
- Criteria of King et al for Failure of Oral Antibiotic Therapy of a Child with Rapid Breathing Community-Acquired Pneumonia
- Decision to Continue Parenteral Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP)
- Duration of Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP)
- Recommendations of Bradley et al for the Prevention of Community-Acquired Pneumonia (CAP) in an Infant
- Factors Influencing the Choice of Antibacterial Therapy in an Infant or Child with Community-Acquired Pneumonia (CAP)
- Clinical Follow-up for Expected Response to Antibiotic Therapy for an Infant or Child with Community-Acquired Pneumonia (CAP)
- Duration of Antibiotic Therapy for a Young Pediatric Patient with Community-Acquired Pneumonia (CAP) and Parapneumonic Effusion or Empyema
- Reducing Recurrence of Clostridium difficile Infection with Bezlotoxumab (Zinplava)
- Model of Park et al for Identifying a Patient with Healthcare-Associated Pneumonia with an Antibiotic-Resistant Pathogen
- Drug Resistance in Pneumonia (DRIP) Score of Webb et al for Antibiotic Resistance in Community-Onset Pneumonia
- Risk Factors of Nicoletti et al for Ciprofloxacin-Resistant Escherichia coli Urinary Tract Infection (UTI) in a Tertiary Care (University) Hospital
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Local Reaction
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Vital Signs
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Systemic Reactions
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Renal Reactions
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Coagulopathy
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Hematologic Reactions
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Basic Chemistry Tests
- FDA Toxicity Grading Scale for Preventive Vaccine Trials: Additional Chemistry Tests
- Criteria of Walter et al for Response to Initial Antibiotic Therapy in a Patient with Early-Onset Acute Stroke-Associated Pneumonia (SAP)
- Predictors of da Silva et al for Adverse Drug Effects in a Patient Treated with Benznidazole for Chaga's Disease (Trypanosoma cruzi)
- Clinical Decision Tree of Goodman et al for Bacteremia Caused By an Extended Spectrum Beta-Lactamase (ESBL) Producing Bacteria
- Score of Schreiber et al for a Antibiotic-Resistant Pathogen in a Patient with Severe Pneumonia and Respiratory Failure
- GSDCS Prediction Score of Vasudevan et al for Nosocomial Multi-Drug Resistant (MDR) Gram Negative Bacilli Infections in a Patient in the Intensive Care Unit (ICU)
- Clinical Risk Score of Augustine et al for Predicting Extended-Spectrum beta-Lactamase Producing Enterobacteriaceae (ESBLE) in a Bloodstream Infection
- Recommendations of the CADTH for Treating Chronic Viral Hepatitis Genotypes 2 to 4 with Direct-Acting Agents
- Recommendations of the CADTH for Treating Chronic Viral Hepatitis Genotype 1 with Direct-Acting Agents
- Algorithm of Huang et al for Using Procalcitonin to Guide Antibiotic Therapy in a Patient with Secondary Peritonitis
- Recommendations for Use of the Cholera Vaccine CVD 103-HgR
- Recommendations of Augustine et al for Treating a Bloodstream Infection (BSI) Caused by an Enterobacteriaceae
- Clinical and Laboratory Findings of Stone et al Associated with Low Risk of Recurrent Surgical Infection After Discontinuation of Antibiotic Therapy
- Algorithm of Halilovic and Heintz for Dosing Antibiotics in a Patient with Cirrhosis
- Indications for Therapeutic Drug Monitoring (TDM) of an Antibiotic
- Indications for Therapeutic Drug Monitoring of Antituberculous Therapy
- Factors of Lane et al Influencing Outpatient versus Inpatient Antibiotic Therapy for an Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Indications of Liu et al for Antibiotic Therapy Following Incision and Drainage of an Abscess Caused by Community-Acquired Methicillin-Resistant Staphylococcus aureus (MRSA)
- Criteria of Schroeck et al for Appropriate Antibiotic Therapy in a Patient with Pharyngitis
- Criteria of Schroeck et al for Inappropriate Antibiotic Therapy in a Patient with Bronchitis
- Criteria of Schroeck et al for Appropriate Antibiotic Therapy in a Patient with Sinusitis
- Criteria of Schroeck et al for Appropriate Therapy in a Patient with Nonspecific Upper Respiratory Tract Infection (URTI)
- Risk Factors of Schroeck et al for Inappropriate Antibiotic Therapy in a Patient with an Upper Respiratory Tract Infection
- Management Protocol of Claeys et al for a Patient with Skin and Skin Structure Infection Guided by the CREST Scoring System
- Paradoxical (Unexplained) Clinical Deterioration in a Patient Being Treated for Tuberculosis
- Adverse Effects of BCG Vaccine to Prevent Tuberculosis
- Benefits of Prophylactic Antibiotics for a Patient with Acute Variceal Hemorrhage and Cirrhosis
- Intravenous Antibiotics and Addiction Team, IVAT) 9 Point Assessment of Rolfe et al for Identifying an Injection Drug User Who Can Receive Parenteral Antibiotics As an Outpatient
- Predictors of Sowunmi et al for Failure of Chloroquine Therapy of Plasmodium falciparum Malaria in a Region of Chloroquine Resistance
- Score of Ciobotaro et al for Predicting Persistent Carriage of Carbapenem-Resistant Enterobacteriaceae
- Risk Factors of Gao et al for Antibiotic Resistant Pseudomonas aeruginosa in a Patient with Bronchiectasis
- Model of Johnson et al for Predicting Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae at Hospital Admission (Duke Model)
- Risk Factors of Garcia-Vidal et al for Multi-Drug Resistant Pseudomonas aeruginosa Causing Bloodstream Infection (BSI) in a Patient with Acute Leukemia
- Difficult to Treat Resistant (DTR) Gram-negative Bacteria
- Risk Factors of Tseng et al for Predicting Colonization with Multidrug-Resistant (MDR) Gram-Negative Bacteria of a Patient Being Admitted to the Hospital
- Risk Factors of Bhargava et al for Colonization with Carbapenem-Resistant Enterobacteriaceae of a Patient Having Contact with a Long-Term Acute Care Facility
- Vaccination-Associated Seizures in a Patient with Mutations in SCN1A
- Adverse Effects of Therapy for the Diagnosis of Chronic Lyme Disease
- STARWAVe Pneumonic of Hay et al for Improved Use of Antibiotic Use in a Child with an Acute Respiratory Infection and Cough
- Antibiotic Discontinuation for a Respiratory Infection Associated with a Positive Respiratory Viral Panel and Low Serum Procalcitonin Concentration
- Criteria for Clinical Failure for a Patient Who Has Been Treated for an Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Criteria of Nathwani et al for Therapeutic Success for a Patient with Acute Bacterial Skin and Skin Structure Infection (ABSSSI) to Antibiotic Therapy
- Recommendations of Walsh et al for Acne Management with Avoidance of Antibiotic Resistance
- Predictors of Yadav et al for Oral Antibiotic Failure of Nonpurulent Skin and Soft Tissue Infections
- Indications for Receipt of the Human Papillomavirus (HPV) Vaccine
- Antibiotic Spectrum Index (ASI)
- CDC Checklist for a Hospital Antibiotic Stewardship Program
- Score of Rattanaumpawan et al for a Fluoroquinolone-Resistant Urinary Tract Infection (UTI) Caused by Gram-Negative Bacteria
- Risk Factors of Tsai et al for Multidrug-Resistant Gram-negative (MDR GN) Bacteremia in the NICU
- Sciatic Nerve Damage After Vaccine Injection into the Buttocks of an Infant or Child
- Failures in Maintaining Temperature During Vaccine Storage
- Risk Factors of Chemaly et al for Cytomegalovirus (CMV) Antiviral Resistance in Transplant Recipients
- Criteria of Chemaly et al for a Refractory Cytomegalovirus (CMV) Infection in Transplant Recipients
- Clinical Risk Prediction Tool of Nochaiwong et al for Antibiotic Treatment Failure in a Patient with Peritoneal Dialysis Related Peritonitis
- Risk Factors of Roldan-Masedo et al for Gentamicin-Resistant Escherichia coli Urinary Tract Infection (UTI) in Children
- Silver Resistance
- Bedside Risk Score of Miller and Johnson for Carbapenem-Resistant Enterobacteriaceae
- Risk Factors of Blanco et al for Colonization With Multidrug-Resistant Acinetobacter baumannii on Admission to the Intensive Care Unit (ICU)
- Multidrug-Resistance Pulmonary Tuberculosis (MDR-TB) Score of Martinez et al
- Predictors of Kliiman and Altraja for Poor Treatment Outcome in Drug-Resistant Pulmonary Tuberculosis
- Predictors of Blondal et al for Recurrence of Multidrug-Resistant or Extensively Drug-Resistant Tuberculosis
- Risk Factors of Dirajlal-Fargo et al for Carbapenem-Resistant Enterobacteriaceae (CRE) in a Pediatric Patient
- Sweet's Syndrome Associated with Vaccination
- Hearing Loss Following Receipt of the Measles-Mumps-Rubells (MMR) Vaccine
- Score of Nesheim et al for Antiretroviral Therapy of an HIV-Exposed Infant
- Administration of Granulocyte Colony Stimulating Factor (G-CSF) in a Pediatric Patient with Neutropenia
- Management of a Research Laboratory Worker with a Macaque-Related Injury and Possible Exposure to Herpes B Virus
- Criteria of Marschall et al for Inadequate Empirical Antibiotic Therapy of Gram-negative Bacteremia
- Recommendations for HPV Vaccination in an Adult
- Model of Frazee et al for Predicting Vancomycin Trough Levels
- 2019 Recommendations for Pneumococcal Vaccination in an Older Adult
- Risk Assessment Stratification Protocol (RASP) for a Possible Exposure to HIV
- Risk Factors of Keller et al for Adverse Drug Events for a Patient Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
- Criteria of Patel et al for Suitability of Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT)
- Categories for Outcomes Associated with Outpatient Parenteral Antibiotic Therapy (OPAT)
- Predictors of Schmidt et al for Unplanned Hospitalization for an Adult Receiving Outpatient Parenteral Antibiotic Therapy (OPAT)
- Model of Ben Ayed et al for Community-Acquired Urinary Tract Infection (CUTI) Caused By a Multidrug-Resistant Enterobacteriaceae
- Antibiotic Resistance in Helicobacter pylori
- Risk Factors of Li et al for Colonization of a Pediatric Patient with an Enterobacteriaceae Producing Extended-Spectrum Beta-Lactamase (ESBL) on Admission to the Intensive Care Unit (ICU)
- Score of Gonzalez del Castillo et al for Multi-Drug Antibiotic Resistance in an Emergency Room Patient
- Risk Factors of Kliiman and Altraja for Resistant Pulmonary Tuberculosis
- Models of Rottier et al for Predicting Bacteremia Caused by a Third-Generation Cephalosporin-Resistant Enterobacteria: Community Onset
- Models of Rottier et al for Predicting Bacteremia Caused by a Third-Generation Cephalosporin-Resistant Enterobacteria: Hospital Onset
- BE3A Score of El-Sherif et al for Response to Direct-Acting Antiviral Therapy for Hepatitis C
- Models of Andriulli et al for Response to Therapy with Peginterferon Plus Ribavirin for Viral Hepatitis C: Model for Rapid Viral Response (RVR)
- Models of Andriulli et al for Response to Therapy with Peginterferon Plus Ribavirin for Viral Hepatitis C: Model for Sustained Viral Response (SVR)
- Criteria of Akhloufi et al for Switching from Intravenous to Oral Antibiotic Therapy
- PEN-FAST Score of Trubiano et al for Evaluating a Patient for Penicillin Allergy
- Adverse Immune-Mediated Events Following Chemotherapy for Lymphatic Filariasis
- EQUAL Score for Mucomycosis Management
- Delayed Antibiotic Therapy of a Urinary Tract Infection (UTI) in a Febrile Child
- Risk Factors of Guarana et al for Shock and Early Death in a Hematology Patient with Febrile Neutropenia
- American Thoracic Society (ATS) Management Strategy for an Adult with Healthcare-Associated Pneumonia
- Causes of Nonresponse to Initial Antibiotic Therapy for Healthcare-Associated Pneumonia (HAP)
- Protocol of Singh et al for Managing a Patient in the Intensvie Care Unit with a Pulmonary Infiltrate
- Model of Mehr et al for Predicting Antibiotic Therapy of a Nursing Home Resident with Pneumonia and Dementia
- Decision Models of Fischer et al for Macrolide Therapy in a Child with Community-Acquired Pneumonia
- Criteria for Switching from Intravenous to Oral Antibiotic Therapy for an Adult with Community-Acquired Pneumonia (CAP)
- Risk Factors of Micek et al for Ineffective Empiric Therapy of Gram-Negative Sepsis
- Serum Procalcitonin and Systemic Bacterial Infection in a Febrile Patient with an Autoimmune Disease
- Protocol of Mintegi et al for Managing a Febrile Infant Under 3 Months of Age Without Antibiotics or Lumbar Puncture
- Simplified Method of Gross et al for Dosing Aztreonam in a Patient with End-Stage Renal Disease
- Conditions That May Be Suitable for Pediatric Outpatient Parenteral Antibiotic Therapy (p-OPAT)
- Bedside Instrument of Zilberberg et al for Carbapenem Resistant Gram-Negative Pathogens in a Complicated Urinary Tract Infection (UTI)
- Model of Wang and Tu for Predicting Multidrug-Resistant Tuberculosis
- Gianotti-Crosti Syndrome (Papular Acrodermatitis) Following Anti-Viral Vaccination
- Protocol of Stevenson et al for Pencillin Allergy in an Outpatient
- Predictors of Mohamed et al for True Penicillin Allergy
- Vaccine Confidence Scale
- Vaccine Conspiracy Beliefs Scale (VCBS)
- Predictors of Roger et al for Unnecessary Antibiotic Therapy in a Hospitalized Patient with Possible Infection
- Risk Factors of Gooiker et al for Excess 1-Year Mortality After Curative Surgery for Colorectal Cancer
- Protocol of Oda et al for Dosing Vancomycin to Achieve a Target Area Under the Concentration-Time Curve
- Equation of Smit et al for Dosing Tobramycin
- Clinical Prediction Model of Peetluk et al for Unsuccessful Outcomes in a Patient Treated for Pulmonary Tuberculosis
- Recommendations of Ellsbury et al for Pneumococcal Vaccination of a Traveler
- Antibiotic Resistance in Neisseria meningitidis Serogroup Y
- CarbaSCORE of Teysseyre et al
- Risk Factors of Pomba et al for Antibiotic-Resistant Bacteria in a Companion Animal
- Clinical Risk Score of Ma et al for Antibiotic-Resistant Bacterial Pneumonia in an Elderly Chinese Adult
- Score of Jeong et al for Predicting Antibiotic-Resistant Pneumonia in an Immunocompetent Adult Acquired Outside of the Hospital
- CREP Risk Prediction Model of Song and Jeong for Carbapenem-Resistant Enterobacteriaceae Colonization of a Patient in an Intensive Care Unit (ICU)
- Risk Factors of Trinh et al for Multidrug-Resistant Pseudomonas aeruginosa Pneumonia in a Patient in the Intensive Care Unit (ICU)
- COVID-19 Vaccine-Induced Thrombotic Thrombocytopenia (Vaccine-Induced Thrombocytopenia and Thrombosis, VITT)
- Common Terminology Severity Scale for a Local Vaccine Site Adverse Event
- Myocarditis Associated with COVID-19 Vaccination
- Vaccine Site Appearance Grading Scale (VSAGS)
- Shoulder Injury Related to Vaccine Administration (SIRVA)
- Conditions Considered Serious Adverse Events in the Vaccine Adverse Event Reporting System (VAERS)
- Vaccine Injury Table
- Guillain-Barre Syndrome Following COVID-19 Vaccination
- Misdiagnosis of a Vaccination-Related Adverse Effect
- Indications and Contraindications for Vaccination with Shingrix (Zoster Vaccine Recombinant)
- Post-Ivermectin or Post-Diethylcarbamazine Loa Loa Encephalopathy
- Risk Factors of Ostrosky-Zeichner et al for Fluconazole Failure in a Patient with Candidemia
- PRoFeSs Score of Pereira et al for Early Treatment Failure in Severe Community-Acquired Pneumonia
- Clinical Tool of Mamtani et al for Predicting Treatment Failure for a Child Being Treated for Pneumonia
- Nomogram of Cheng et al for Predicting Refractory Mycoplasma pneumoniae Pneumonia in a Child
- Risk Factors of O'Brien et al for Failure of Antibiotic Therapy for a Patient with Buruli Ulcer
- Ranking of Weiss et al for De-Escalation of Beta-Lactam Antibiotics
- Nomogram of Batchelder et al for Dosing Vancomycin in an Obese Adult (Cone Health Modified Vancomycin Nomogram)
- Method of Smit et al for Dosing Gentamicin in an Obese Adult with Normal Renal Function
- Risk Factors for 13-Valent Conjugated Pneumococcal Vaccine Failure in a Pediatric Patient
- Vancomycin-Resistant Enterococcus Bloodstream Infection Score of Webb et al
- Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT)
- Score of Meier and Berger for Identifying a Nonresponder to Hepatitis B Vaccination
- TREAT-B Score for When to Treat Viral Hepatitis B (HBV)
- Score of Rincon-Lopez et al for Guiding Antibiotic Therapy in a Child with Sickle Cell Disease and Fever
- Risk Factors of Chu et al for Initially Inappropriate Antibiotic Therapy of Neonate with Gram-Negative Bacteremia
- Criteria of Garber et al for Restricting Empiric Antibiotic Therapy to Prevent Early-Onset Infection in a Preterm Neonate
- Indications for Dengue Vaccination in a Pediatric Patient
- Risk Prediction Model of Durojaiye et al for 30-Day Unplanned Hospitalization for a Patient Receiving Outpatient Parenteral Antimicrobial Therapy (OPAT)
- Clinical Prediction Tool of Wang et al for Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-EB) Bloodstream Infection in Solid Organ Transplant Recipients
- Non-Infectious Complications of Bacillus Calmette-Guerin (BCG) Therapy for Bladder Cancer
- Vaccine-Associated Leukocytoclastic Vasculitis (LCV)
- Exacerbation of the Systemic Capillary Leak Syndrome (SCLS) After COVID-19 Vaccination
- Risk Factors of Aussy et al for Treatment Failure for an Ambulatory Patient with Scabies
- Survey of Opel et al for Identifying a Vaccine-Hesitant Parent
- EQUAL Trichosporon Score 2022
- Criteria of Dinh et al for Antibiotic Treatment Failure in Community-Acquired Pneumonia
- Risk Factors of Montravers et al for Therapeutic Failure or Death in Post-Operative Peritonitis
- Risk Factors of Lorton for Suboptimal Initial Management of a Severe Community-Onset Pediatric Bacterial Infection (COSBI)
- Algorithm of Haukoos et al for HIV Pre-Exposure Prophylaxis
- Adrenal Insufficiency Following Vaccination
- Predictors of Starrels et al for Inappropriate Antibiotic Use by an Intravenous Drug Abuser
- Model of Buendia and Feliciano-Alfonso for Inappropriate Prescribing for Acute Bronchiolitis
- Classification of Wu et al for Appropriate Antibiotic Use with Infections Encountered in Primary Care
- Criteria of Davar et al for Switching from an Intravenous to Oral Antibiotic Regimen
- Prognostic Factors of Fisher et al for a Solid Organ Transplant Recipient with Ganciclovir Resistant Cytomegalovirus (CMV)
- Risk Factors of Horton et al Associated with Treatment Failure of Fracture-Related Infections
- Factors of Pelegrin et al for Treatment Failure of a Ventriculoperitoneal (VP) Shunt Infection
- Indications and Contraindications for Mpox JYNNEOS Vaccination
- Observations of Zahar et al for Appropriate and Inappropriate Prescribing of Aminoglycosides
- Inappropriate Malaria Chemoprophylaxis
- Risk Factors of Jacob et al for Antibiotic Resistance in a Patient with Acute Pyelonephritis in India
- Predictors of Gudiol et al for a Bloodstream Infection with a Multidrug Resistant Pseudomonas aerugnosa in a Neutropenic Patient
- Score of Moghnieh et al for Carbapenem Resistance in an Inpatient with a Third Generation Cephalosporin Resistant Enterobacterales
- Heteroresistance
- Risk Factors for Multidrug Resistant Pseudomonas aeruginosa Infection in an Immunocompromised Patient
- Risk Factors of Kandemir et al for Multi-Drug Resistant (MDR) Bacteria Infecting a Diabetic Foot
- Score of Hernandez-Jimenez et al for Predicting Infection with a Multidrug-Resistant Pseudomonas aeruginosa
- Algorithm of Wood et al for Managing a Patient with a Possible Hypersensitivity Reaction to a Vaccine
- Meningitis Following After Measles, Mumps, and Rubella (MMR) Vaccine
- CDC Recommendations for Respiratory Syncytial Virus (RSV) Vaccination of an Older Adult
- Impaired Vaccine Response to COVID-19 Vaccination in a Patient Treated with Rituximab
- Predictors of Klastersky et al for Outpatient Oral Antibiotic Therapy of a Cancer Patient with Febrile Neutropenia
- Predictors of Mandell et al for Nonresponse of an Adult with Community-Acquired Pneumonia (CAP) to Antibiotic Therapy
- Predictors of Basnet et al for Treatment Failure in a Young Child Hospitalized for Severe Pneumonia
- Pros and Cons of Antibiotic Therapy in a Patient with Dementia